Analyst firms · Morgan Stanley · HOLX

Morgan Stanley HOLX price target and rating history

Hologic Inc. (HOLX) · Health Care

Morgan Stanley rates Hologic Inc. (HOLX) Equal-Weight with a $75 price target, as of its latest action on Feb 3, 2022. It has published 3 rating actions on HOLX since July 2021, including 0 upgrades and 0 downgrades.

Current rating
Equal-Weight
Price target
$75
Median target, all firms
Too few
Actions on HOLX
3

Morgan Stanley price target on HOLX

$76$76$7520222023202420252026
Morgan Stanley price target on HOLX, each point a stated target, July 2021 to February 2022.

Every Morgan Stanley rating on HOLX

How other firms rate HOLX

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Argus ResearchHoldJan 12, 2026
Evercore ISIIn-line$78Jan 5, 2026
BNP Paribas ExaneNeutral$79Nov 21, 2025

Questions about Morgan Stanley and HOLX

What is Morgan Stanley's price target for HOLX?
Morgan Stanley's latest stated price target for Hologic Inc. (HOLX) is $75, from its action on Feb 3, 2022.
What is Morgan Stanley's rating on HOLX?
Morgan Stanley rates HOLX Equal-Weight, a neutral rating, as of Feb 3, 2022.
When did Morgan Stanley last change its view on HOLX?
On Feb 3, 2022, Morgan Stanley cuts its price target to $75 from $76, keeps Equal-Weight.

More HOLX rating histories

All Morgan Stanley ratingsHOLX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.